DALE STEPHEN has filed 8 insider transactions across 1 company since January 2023.
Most recent transaction: a sale of 4400 shares of Kura Oncology, Inc. ($KURA) on January 29, 2024.
Activity breakdown: 0 open-market purchases and 5 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 29, 2024 | Kura Oncology, Inc. | $KURA | DALE STEPHEN | Chief Medical Officer | S | Common Stock | 4400 | $17.80 | 46,400.0000 | 73,229,000 | 8.66% | 0.01% |
| Jan. 29, 2024 | Kura Oncology, Inc. | $KURA | DALE STEPHEN | Chief Medical Officer | S | Common Stock | 2758 | $17.80 | 43,642.0000 | 73,229,000 | 5.94% | 0.00% |
| Jan. 30, 2024 | Kura Oncology, Inc. | $KURA | DALE STEPHEN | Chief Medical Officer | S | Common Stock | 4825 | $21.55 | 38,817.0000 | 73,229,000 | 11.06% | 0.01% |
| Jan. 2, 2024 | Kura Oncology, Inc. | $KURA | DALE STEPHEN | Chief Medical Officer | A | Option to purchase common stock | 185000 | $0.00 | 185,000.0000 | 73,229,000 | 9999.99% | 0.25% |
| Feb. 16, 2023 | Kura Oncology, Inc. | $KURA | DALE STEPHEN | Chief Medical Officer | A | Common Stock | 23125 | $0.00 | 50,800.0000 | 66,990,000 | 83.56% | 0.03% |
| Feb. 16, 2023 | Kura Oncology, Inc. | $KURA | DALE STEPHEN | Chief Medical Officer | A | Option to purchase common stock | 185000 | $0.00 | 185,000.0000 | 66,990,000 | 9999.99% | 0.28% |
| Jan. 27, 2023 | Kura Oncology, Inc. | $KURA | DALE STEPHEN | Chief Medical Officer | S | Common Stock | 4385 | $13.89 | 32,515.0000 | 66,990,000 | 11.88% | 0.01% |
| Jan. 27, 2023 | Kura Oncology, Inc. | $KURA | DALE STEPHEN | Chief Medical Officer | S | Common Stock | 4840 | $13.87 | 27,675.0000 | 66,990,000 | 14.89% | 0.01% |